Cargando…

Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry

The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Driver, Taran, Bachhawat, Nikhil, Frasinski, Leszek J., Marangos, Jonathan P., Averbukh, Vitali, Edelson-Averbukh, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234510/
https://www.ncbi.nlm.nih.gov/pubmed/34207274
http://dx.doi.org/10.3390/molecules26123728
_version_ 1783714100430241792
author Driver, Taran
Bachhawat, Nikhil
Frasinski, Leszek J.
Marangos, Jonathan P.
Averbukh, Vitali
Edelson-Averbukh, Marina
author_facet Driver, Taran
Bachhawat, Nikhil
Frasinski, Leszek J.
Marangos, Jonathan P.
Averbukh, Vitali
Edelson-Averbukh, Marina
author_sort Driver, Taran
collection PubMed
description The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the fragment ions from more than a single precursor ion. The totality of the fragment ion peaks in chimera spectra cannot be assigned to a single peptide sequence, which contradicts a fundamental assumption of the standard automated MS/MS spectra analysis tools, such as protein database search engines. This calls for a diagnostic method able to identify chimera spectra to single out the cases where this assumption is not valid. Here, we demonstrate that, within the recently developed two-dimensional partial covariance mass spectrometry (2D-PC-MS), it is possible to reliably identify chimera spectra directly from the two-dimensional fragment ion spectrum, irrespective of whether the co-isolated peptide ions are isobaric up to a finite mass accuracy or isomeric. We introduce ‘3-57 chimera tag’ technique for chimera spectrum diagnostics based on 2D-PC-MS and perform numerical simulations to examine its efficiency. We experimentally demonstrate the detection of a mixture of two isomeric parent ions, even under conditions when one isomeric peptide is at one five-hundredth of the molar concentration of the second isomer.
format Online
Article
Text
id pubmed-8234510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82345102021-06-27 Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry Driver, Taran Bachhawat, Nikhil Frasinski, Leszek J. Marangos, Jonathan P. Averbukh, Vitali Edelson-Averbukh, Marina Molecules Article The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the fragment ions from more than a single precursor ion. The totality of the fragment ion peaks in chimera spectra cannot be assigned to a single peptide sequence, which contradicts a fundamental assumption of the standard automated MS/MS spectra analysis tools, such as protein database search engines. This calls for a diagnostic method able to identify chimera spectra to single out the cases where this assumption is not valid. Here, we demonstrate that, within the recently developed two-dimensional partial covariance mass spectrometry (2D-PC-MS), it is possible to reliably identify chimera spectra directly from the two-dimensional fragment ion spectrum, irrespective of whether the co-isolated peptide ions are isobaric up to a finite mass accuracy or isomeric. We introduce ‘3-57 chimera tag’ technique for chimera spectrum diagnostics based on 2D-PC-MS and perform numerical simulations to examine its efficiency. We experimentally demonstrate the detection of a mixture of two isomeric parent ions, even under conditions when one isomeric peptide is at one five-hundredth of the molar concentration of the second isomer. MDPI 2021-06-18 /pmc/articles/PMC8234510/ /pubmed/34207274 http://dx.doi.org/10.3390/molecules26123728 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Driver, Taran
Bachhawat, Nikhil
Frasinski, Leszek J.
Marangos, Jonathan P.
Averbukh, Vitali
Edelson-Averbukh, Marina
Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title_full Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title_fullStr Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title_full_unstemmed Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title_short Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
title_sort chimera spectrum diagnostics for peptides using two-dimensional partial covariance mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234510/
https://www.ncbi.nlm.nih.gov/pubmed/34207274
http://dx.doi.org/10.3390/molecules26123728
work_keys_str_mv AT drivertaran chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry
AT bachhawatnikhil chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry
AT frasinskileszekj chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry
AT marangosjonathanp chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry
AT averbukhvitali chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry
AT edelsonaverbukhmarina chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry